Morgan Stanley upgrades to STRONG BUY from Outperform; anticipates additional appreciation potential for IDPH now that Zevalin concerns with the FDA have been addressed and focus returns to strong Rituxan growth.
Figured barginhuner was doing what could be done to get his/her number of posts up there to keep up with the Big Boys/Girls.At least it wasn't spam! :-)
Ridiculous.On Level 2,MSCO is selling at 54.06, 54.70MSCO only willing to buy for 53.12That doesn't show the action of 'STRONG BUY '.
MSDW upgrade of AMAT yesterday was a pump and dump.
Now MSCO is trying to sel @53.50Morgan Stanley STRONG BUY rating is not creditable.